Detailed explanation of medical insurance coverage and price of Venetoclax

Venetoclax (), a targeted therapy drug designed for specific hematological malignancies, is being used for chronic lymphocytic leukemia (CLL) , small lymphocytic lymphoma (SLL) and acute myeloid leukemia (AML) patients bring new treatment prospects. It is unique in that it inhibits BCL-2 (BCL-2) protein, an anti-apoptotic protein highly expressed in cancer cells. By blocking the function of this protein, venetoclax can effectively promote cancer cells to enter the apoptosis process, thereby reducing the survival and spread of malignant cells, becoming a powerful weapon in the treatment of hematological tumors, especially for patients who have developed resistance to other treatments.

Fortunately, venetoclax has been officially launched in the Chinese market and has been included in the national medical insurance directory. This policy has undoubtedly brought good news to patients, meaning that they can enjoy medical insurance reimbursement during treatment, thus greatly reducing their financial burden. This financial support is particularly important for patients who require long-term use of the drug.

In the domestic market, the price of 100mg venetoclax (28 tablets) is about RMB2000 yuan. However, since the drug has been included in the medical insurance catalog, the actual cost paid by patients will vary according to the reimbursement ratio of medical insurance in various places. Therefore, it is recommended that patients consult the local medical insurance department or hospital pharmacy for specific reimbursement policies before using drugs to understand the final out-of-pocket amount.

In general, as a highly effective anti-cancer drug, the inclusion of venetoclax in medical insurance will undoubtedly provide patients with more treatment opportunities and reduce financial pressure. But at the same time, because this drug is still a relatively expensive targeted therapy drug, patients should use it rationally under the guidance of a doctor and understand their personal medical insurance policy in a timely manner to ensure the smooth progress of treatment.